Found: 4
Select item for more details and to access through your institution.
Pharmacokinetics and pharmacodynamics of a single dose Nilotinib in individuals with Parkinson's disease.
- Published in:
- Pharmacology Research & Perspectives, 2019, v. 7, n. 2, p. 1, doi. 10.1002/prp2.470
- By:
- Publication type:
- Article
Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease: A Phase 2 Randomized Clinical Trial.
- Published in:
- JAMA Neurology, 2020, v. 77, n. 3, p. 309, doi. 10.1001/jamaneurol.2019.4200
- By:
- Publication type:
- Article
Long‐Term Safety and Clinical Effects of Nilotinib in Parkinson's Disease.
- Published in:
- Movement Disorders, 2021, v. 36, n. 3, p. 740, doi. 10.1002/mds.28389
- By:
- Publication type:
- Article
Safety, target engagement, and biomarker effects of bosutinib in dementia with Lewy bodies.
- Published in:
- Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2022, v. 8, n. 1, p. 1, doi. 10.1002/trc2.12296
- By:
- Publication type:
- Article